Your browser doesn't support javascript.
loading
New insights into the clinical characteristics of SETD2-mutated acute myeloid leukaemia.
Zhang, Xiang; Wang, Ziwei; Sun, Jiewen; Liu, Lixia; Qin, Jiayue; Huang, Aijie; Yang, Min; Lou, Yinjun; Tang, Gusheng; Mao, Liping; Qian, Jiejin; Wei, Juying; Mai, Wenyuan; Meng, Haitao; Yang, Jianmin; Tong, Hongyan; Wang, Jianmin; Yu, Wenjuan; Ni, Xiong; Jin, Jie.
Afiliación
  • Zhang X; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China.
  • Wang Z; Department of Hematology, Institute of Hematology, Changhai Hospital, Shanghai, People's Republic of China.
  • Sun J; Institute of Genetics and Department of Human Genetics, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China.
  • Liu L; Acornmed Biotechnology Co. Ltd., Tianjin, People's Republic of China.
  • Qin J; Acornmed Biotechnology Co. Ltd., Tianjin, People's Republic of China.
  • Huang A; Department of Hematology, Institute of Hematology, Changhai Hospital, Shanghai, People's Republic of China.
  • Yang M; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China.
  • Lou Y; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China.
  • Tang G; Department of Hematology, Institute of Hematology, Changhai Hospital, Shanghai, People's Republic of China.
  • Mao L; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China.
  • Qian J; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China.
  • Wei J; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China.
  • Mai W; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China.
  • Meng H; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China.
  • Yang J; Department of Hematology, Institute of Hematology, Changhai Hospital, Shanghai, People's Republic of China.
  • Tong H; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China.
  • Wang J; Department of Hematology, Institute of Hematology, Changhai Hospital, Shanghai, People's Republic of China.
  • Yu W; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China.
  • Ni X; Department of Hematology, Institute of Hematology, Changhai Hospital, Shanghai, People's Republic of China.
  • Jin J; Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China.
Br J Haematol ; 202(1): 111-115, 2023 07.
Article en En | MEDLINE | ID: mdl-37038274
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Nucleofosmina Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Br J Haematol Año: 2023 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Nucleofosmina Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Br J Haematol Año: 2023 Tipo del documento: Article Pais de publicación: Reino Unido